-

ORPEA Proposes the Appointment of Mazars S.A and Deloitte & Associés at the Annual General Meeting of 28 July 2022

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News:

ORPEA (Paris:ORP):

Due to the expiry of the mandate of Deloitte & Associés at the end of the next General Meeting, the Audit Committee, in coordination with the Executive Board, organised a selection process to study the candidates for the position of statutory auditor.

After examining the files and the submissions of the firms that responded to the call for tenders, ORPEA's Board of Directors, meeting on 1 July 2022, decided, on the recommendation of the Audit Committee, to submit to the General Meeting of Shareholders of 28 July 2022:

- The appointment of Mazars S.A. as statutory auditor for a period of six financial years, i.e. until the end of the General Meeting called to approve the accounts for the financial year ending 31 December 2027;

- The reappointment of Deloitte & Associés as statutory auditor of the Company for a period of six financial years, i.e. until the end of the General Meeting called to approve the financial statements for the year ending 31 December 2027.

As part of the selection process, the teams from Mazars and Deloitte demonstrated their ability to audit the accounts of ORPEA SA and its subsidiaries according to best practices.

Moreover, it appeared that these two candidates were the best able to meet the requirement of a reinforced control of the Company while ensuring continuity alongside the third co-auditor, the firm Saint-Honoré BK&A, whose mandate is still in progress.

About ORPEA (www.orpea-corp.com)

Founded in 1989, ORPEA is one of the world leaders in Dependency care (nursing homes, assisted living, post-acute and rehabilitation hospitals, mental health hospitals, home care services)

ORPEA is listed on Euronext Paris (ISIN code: FR0000184798) and is a member of the SBF 120, STOXX 600 Europe, MSCI Small Cap Europe and CAC Mid 60 indices.

Contacts

Investor Relations Director
ORPEA
Benoit Lesieur
Investor Relations Director
b.lesieur@orpea.net

Investor Relations
NewCap
Dusan Oresansky
Tel.: +33 (0)1 44 71 94 94
orpea@newcap.eu

Media Relations
Image 7
Charlotte Le Barbier
Tel.: +33 (0)6 78 37 27 60
clebarbier@image7.fr

Laurence Heilbronn
Tel.: 06 89 87 61 37
lheilbronn@image7.fr

ORPEA

BOURSE:ORP

Release Versions

Contacts

Investor Relations Director
ORPEA
Benoit Lesieur
Investor Relations Director
b.lesieur@orpea.net

Investor Relations
NewCap
Dusan Oresansky
Tel.: +33 (0)1 44 71 94 94
orpea@newcap.eu

Media Relations
Image 7
Charlotte Le Barbier
Tel.: +33 (0)6 78 37 27 60
clebarbier@image7.fr

Laurence Heilbronn
Tel.: 06 89 87 61 37
lheilbronn@image7.fr

More News From ORPEA

emeis Announces Its Early Exit From the Accelerated Safeguard Plan

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News: emeis (Paris:EMEIS) announces its early exit from the accelerated safeguard plan on February 20, 2026, following the approval of its request by the Nanterre Economic Court. This early exit, achieved in record time, was made possible by: - the implementation of a major disposal plan (€2.45 billion in disposals completed or secured since mid-2022) - the strengthening of emeis S.A.'s balance sheet structure since December 18, 2025 with the raising...

emeis: Activity and revenue at the end of 2025 (unaudited)1

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News: emeis (Paris:EMEIS): Laurent Guillot, Chief Executive Officer: "We are proud of our performance in 2025, with results that demonstrate that we are delivering on our commitments and in line with our strategy. The recent announcement of the creation of our property company Isemia, the completion of our disposal plan and the strengthening of our balance sheet structure already allow us to anticipate an accelerated exit from the safeguard plan in r...

emeis Announces the Creation of Isemia, a Real Estate Company Dedicated to Healthcare Real Estate in Europe

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News: In accordance with the agreements signed and announced on September 23, 2025, emeis (Paris:EMEIS) announces the creation of Isemia, its healthcare real estate company dedicated to healthcare real estate assets operated by the Group, with its partners Farallon Capital and TwentyTwo Real Estate. emeis has thus received €761 million from its partners, representing 62% of the last appraised value1 of the assets held by this vehicle, thereby immedia...
Back to Newsroom